Literature DB >> 10403814

Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.

K Murakami1, T Ide, M Suzuki, T Mochizuki, T Kadowaki.   

Abstract

The alpha isoform of peroxisome proliferators-activated receptor (PPAR) is activated by fatty acids, their metabolites, and the fibrate class of lipid-lowering agents. To test the ability of these activators to directly bind the ligand-binding domain of human PPARalpha, we performed a competitive binding assay using radiolabeled [(3)H]KRP-297, a known ligand for human PPARalpha. Long-chain fatty acids and eicosanoids were even more potent ligands for human PPARalpha than the hitherto most potent PPARalpha ligand WY-14,643. Moreover, these natural ligands avidly activated this receptor in a transient transcriptional assay. This study provides the direct evidence that human PPARalpha is activated through the direct binding of fatty acids and eicosanoids, as well as of a fibrate, to its ligand-binding domain. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403814     DOI: 10.1006/bbrc.1999.0951

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression.

Authors:  Marc van Bilsen; Ger J van der Vusse; Andries J Gilde; Martijn Lindhout; Karin A J M van der Lee
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Two butenolides with PPARα agonistic activity from a marine-derived Streptomyces.

Authors:  Yasuhiro Igarashi; Marumi Ikeda; Satoshi Miyanaga; Hiroaki Kasai; Yoshikazu Shizuri; Nobuyasu Matsuura
Journal:  J Antibiot (Tokyo)       Date:  2014-11-12       Impact factor: 2.649

3.  Long-term effects of acute low-dose ionizing radiation on the neonatal mouse heart: a proteomic study.

Authors:  Mayur V Bakshi; Zarko Barjaktarovic; Omid Azimzadeh; Stefan J Kempf; Juliane Merl; Stefanie M Hauck; Per Eriksson; Sonja Buratovic; Michael J Atkinson; Soile Tapio
Journal:  Radiat Environ Biophys       Date:  2013-07-24       Impact factor: 1.925

4.  Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonists.

Authors:  K Murakami; T Ide; T Nakazawa; T Okazaki; T Mochizuki; T Kadowaki
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

Review 5.  Eicosanoid storm in infection and inflammation.

Authors:  Edward A Dennis; Paul C Norris
Journal:  Nat Rev Immunol       Date:  2015-07-03       Impact factor: 53.106

6.  Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.

Authors:  Shuso Takeda; Eriko Ikeda; Shengzhong Su; Mari Harada; Hiroyuki Okazaki; Yasushi Yoshioka; Hajime Nishimura; Hiroyuki Ishii; Kazuhiro Kakizoe; Aya Taniguchi; Miki Tokuyasu; Taichi Himeno; Kazuhito Watanabe; Curtis J Omiecinski; Hironori Aramaki
Journal:  Toxicology       Date:  2014-10-05       Impact factor: 4.221

Review 7.  Diet, fatty acids, and regulation of genes important for heart disease.

Authors:  John P Vanden Heuvel
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 8.  A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation.

Authors:  Sander Michel Houten; Ronald J A Wanders
Journal:  J Inherit Metab Dis       Date:  2010-03-02       Impact factor: 4.982

9.  Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice.

Authors:  Yuhui Shi; James J Pestka
Journal:  J Nutr Biochem       Date:  2008-07-07       Impact factor: 6.048

Review 10.  Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.

Authors:  Matthew W Buczynski; Darren S Dumlao; Edward A Dennis
Journal:  J Lipid Res       Date:  2009-02-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.